98%
921
2 minutes
20
The clinical ramifications of adaptive servo-ventilation (ASV) therapy have stirred debate within the medical community. Given the potential detrimental effect of elevated expiratory positive airway pressure (EPAP) on cardiac output, we hypothesized that relatively lower EPAP may be recommended for successful ASV therapy. In-hospital patients with congestive heart failure refractory to medical therapy were included in the prospective cohort study of ASV therapy on prognosis in repeatedly hospitalized patients with chronic heart failure: longitudinal observational study of effects on readmission and mortality (SAVIOR-L) study. Assignment to either the ASV treatment group or the medical management group was at the discretion of the attending physicians. For the purposes of this retrospective study, our focus remained solely on the ASV cohort. We conducted an extensive analysis to elucidate the influence of lower EPAP settings on midterm mortality. A total of 108 patients were included. The median age was 74 years, and 83 (77%) patients were male. The median EPAP setting employed was 4 cmHO, with 60 patients subjected to EPAP levels below 5 cmHO. There were no significant differences in the baseline characteristics between the lower and higher EPAP groups, which were divided at the EPAP cutoff of 4.5 cmHO (p > 0.05 for all). A trend toward reduced mortality emerged among patients with EPAP settings below 5 cmHO, exhibiting a hazard ratio of 0.48 (95% confidence interval 0.22-1.07, p = 0.072) after adjusting for potential confounding factors: 2-year mortality 26% vs. 38%; p = 0.095. Heart failure readmission rates were not significantly different between the two groups (p = 0.61). The adoption of relatively lower EPAP settings during ASV therapy may be advisable. Such an approach has the potential to ameliorate mortality rates while concurrently maintaining heart failure recurrence rates at levels commensurate with those with default EPAP settings.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00380-024-02457-8 | DOI Listing |
Respir Med Res
August 2025
Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique F-75005 Paris, France; AP-HP, Groupe Hospitalier Universitaire APHP-Sorbonne Université, hôpital Pitié-Salpêtrière, Département R3S F-75005 Paris, France; Fédération Hospitalo-Universitaire "BREAT
Background: Psychological interventions such as medical hypnosis, cognitive-behavioral therapy (CBT), and mindfulness-based techniques are emerging as promising tools in the management of persistent dyspnea. Their integration into clinical practice, however, is limited by the scarcity of validated outcome measures in non-English languages.
Objectives: This study aimed to provide linguistically validated French versions of four questionnaires selected for their potential relevance in assessing the psychological and perceptual dimensions of dyspnea: the Breathlessness Catastrophizing Questionnaire (BCQ), the Breathlessness Beliefs Questionnaire (BBQ), the COPD Self-Efficacy Scale (CSES), and the Three-Domain Interoceptive Sensations Questionnaire (THISQ).
Clin Neurophysiol
August 2025
Clinical Neurophysiology Department, AP-HP, Hôpital Necker Enfants Malades, Paris, France; Paris Cité University, Paris, France; Centre de référence des pathologies neuromusculaires Paris-Nord-Est, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
Objective: Higher compound muscle action potentials (CMAP) amplitudes are associated with motor milestones acquisitions in patients with symptomatic early onset spinal muscular atrophy (SMA) after gene therapy (GT). This study aimed to propose a predictive model for the evolution of CMAP amplitudes over 36 months in these patients.
Methods: Nineteen SMA patients (mean age 8.
Muscle Nerve
September 2025
Faculty of Medicine, Department of Neurology, Akdeniz University, Antalya, Türkiye.
Introduction/aims: The biological changes in motor neurons and motor axons that correlate with the clinical benefits of nusinersen, an antisense oligonucleotide, in spinal muscular atrophy (SMA) remain poorly understood. This study aimed to investigate changes in axonal excitability and motor unit number estimation (MUNE) parameters following a four-dose loading regimen of nusinersen in adult SMA patients.
Methods: Adult patients with SMA were assessed using the Hammersmith Functional Motor Scale Expanded (HFMSE) and the Medical Research Council (MRC) scale at baseline and after nusinersen treatment.
EBioMedicine
August 2025
Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, 30 Wellington Street, Barcelona, 08005, Spain; Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, 88 Doctor Aiguader Street, Ciutat Vella, Barcelona, 08003, Spain; Hospital del Mar Researc
Background: Short telomere length (TL), a hallmark of biological ageing, has been associated with an increased risk of Alzheimer's disease (AD), but its pathophysiological role remains unclear. This study explored the relationship between blood leukocyte TL (LTL), cerebrospinal fluid (CSF) AD biomarkers changes, and brain structure across early stages of the AD continuum.
Methods: We included 346 cognitively unimpaired participants (aged 49-71) from the ALFA cohort, enriched for AD risk (53.
Cureus
July 2025
Anesthesiology, Father Muller Medical College, Mangalore, IND.
Snake envenomation is a major health concern in tropical countries. Russell's viper, one of the "big four" venomous snakes in India, is known for its hemotoxic venom that commonly causes coagulopathy, spontaneous bleeding, and local tissue damage. However, ischemic strokes following viper envenomation are rare and underreported.
View Article and Find Full Text PDF